The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing of Shares

23 Dec 2013 07:00

RNS Number : 1796W
Akers Biosciences, Inc.
23 December 2013
 



 

23 December 2013

Akers Biosciences, Inc.

("ABI"or the "Company")

Placing of Shares

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION OR DISSEMINATION IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Akers Biosciences, Inc. (the "Company') (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the Company has raised £625,000 gross (approximately $1 million) through a placing of depository interests representing 145,349 its common shares, no par value per share (the "Placing Shares") to institutional and other investors at a price of 430 pence per share.

Thomas A. Nicolette, President and Chief Executive Officer of ABI, commented:

"We are pleased with the support from institutional and other investors as we approach important milestones in the Company's development in 2014."

The Placing

The Placing has raised a total of £625,000 through the issue of 145,349 Placing Shares at the placing price of 430 pence per share. The net proceeds received by the Company taking into account the shares taken in lieu of fees and expenses by the Company's advisors is £584,151.

The Placing Shares have been issued on a non-pre-emptive basis pursuant to the Company's existing shareholder authority.

The Placing Shares have been issued as fully paid and rank pari passu in all respects with the existing common shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued. Application has been made for admission to AIM of the Placing Shares ("Admission") which is expected to occur, and trading to commence, on or around 8.00 am on 30 December 2013.

Total voting rights

Following Admission, the Company's total issued share capital will comprise of 2,199,114 common shares of no par value ("Common Shares"). This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health status information, both rapidly and directly, to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's stateoftheart rapid diagnostic assays can be performed virtually anywhere, in minutes, since time is always of essence. ABI is aligned with high volume medical product distributors to help facilitate the Company's growth into a major, worldwide competitor in the field of rapid diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com

 

 

Enquiries:

 

Thomas A. Nicolette

President and CEO

Tel. +1 856 848 8698

 

Antony Legge or James Thomas

Daniel Stewart & Company plc (Nomad and Broker)

Tel. +44 (0)20 7776 6550

 

Ben Simons

Vigo Communications

Tel. +44 (0) 20 7016 9574

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELFFIIFILFFIV
Date   Source Headline
25th Jul 20074:42 pmRNSDirector/PDMR Shareholding
25th Jul 20072:54 pmRNSDirector/PDMR Shareholding
18th Jul 20077:01 amRNSDirector/PDMR Shareholding
18th Jul 20077:00 amPRNDirector Shareholding - Restatement
17th Jul 20077:00 amPRNAppointment of CFO
6th Jul 200712:35 pmPRNIssue of Equity
3rd Jul 20077:00 amPRNDirector/PDMR Shareholding
29th Jun 20071:27 pmRNSAnnual Report and Accounts
29th Jun 20078:26 amRNSDirector/PDMR Shareholding
26th Jun 20077:00 amPRNFinal Results
3rd May 20077:00 amPRNUnited States Military Contract
26th Mar 20077:00 amPRNUK Distribution Agreement
22nd Mar 20077:00 amPRNUK Orders
15th Mar 20077:00 amPRNDirectorate Change
14th Mar 20073:52 pmRNSAdditional Listing
9th Mar 20073:14 pmRNSAdditional Listing
20th Feb 20077:00 amPRNStrategic Update
6th Feb 20079:17 amRNSAdditional Listing
1st Feb 20077:00 amPRNDirector Share Purchase
24th Jan 20077:00 amPRNAcquisition
18th Jan 20077:00 amPRNTrading & Product Update
3rd Jan 20074:40 pmRNSDirector/PDMR Shareholding
21st Dec 200611:52 amRNSTotal Voting Rights
14th Dec 20067:00 amPRNExpansion of Home Diagnostic Product Line
10th Nov 20062:27 pmRNSIssue of Equity
30th Oct 20067:00 amPRNDistribution Agreement
24th Oct 20069:36 amRNSIssue of Equity
20th Oct 20063:32 pmRNSAdditional Listing
11th Oct 20067:00 amPRNU.S. Department of Transport Approval
4th Sep 200611:18 amRNSAdditional Listing
23rd Aug 20064:43 pmRNSAdditional Listing
4th Aug 20064:24 pmRNSAdditional Listing
30th Jun 20064:50 pmRNSAnnual Report and Accounts
11th May 20067:00 amPRNDirectorate Change
10th May 20067:00 amPRNResult of AGM
3rd May 20067:00 amPRNFDA Clearance for Rapid Alcohol Breathalyzers
24th Apr 20064:00 pmRNSHolding(s) in Company
4th Apr 20067:00 amPRNFinal Results
3rd Apr 20061:09 pmPRNMajor Distribution Agreement
3rd Mar 20064:03 pmRNSAdditional Listing
28th Feb 20067:00 amPRNAcquisition of WNCK, Inc.
13th Feb 20067:00 amPRNTrading Update
3rd Feb 200612:52 pmRNSAdditional Listing
30th Jan 200610:41 amRNSHolding(s) in Company
27th Jan 20061:34 pmRNSIssue of Equity
3rd Jan 20067:00 amPRNRe. Increased Production Facilities
28th Dec 20053:30 pmRNSHolding(s) in Company
19th Dec 20059:53 amRNSIssue of Equity
9th Dec 20055:46 pmRNSDirector/PDMR Shareholding
30th Nov 200511:27 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.